Literature DB >> 10609126

Central precocious puberty. An overview of diagnosis, treatment, and outcome.

P A Lee1.   

Abstract

Central precocious puberty (CPP) is physiologically normal puberty beginning early. It is the consequence of early increased regulation of gonadotropin releasing hormone (GnRH) stimulation of pituitary gonadotropin release causing pubertal changes and accelerated growth. GnRH stimulation testing is the definitive diagnostic test--pubertal gonadotropin responses being indicative of CPP. Among patients with progressive CPP, GnRH analogue therapy is effective by decreased regulation of gonadotropin secretion. Pubertal progression is stopped, and accelerated growth rate and compromised adult height are precluded or alleviated. Outcome data have not identified unusual sequelae.

Entities:  

Mesh:

Year:  1999        PMID: 10609126     DOI: 10.1016/s0889-8529(05)70108-0

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  11 in total

Review 1.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

2.  Gonadotropin-releasing hormone stimulation test for precocious puberty.

Authors:  Han Kyul Kim; Seung Jung Kee; Ji Yeon Seo; Eun Mi Yang; Hong Jae Chae; Chan Jong Kim
Journal:  Korean J Lab Med       Date:  2011-10-03

3.  Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?

Authors:  Dong Seong Lee; Na Yung Ryoo; Sun Hee Lee; Sollip Kim; Jae Hyun Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-12-31

Review 4.  Endocrinopathies in survivors of childhood neoplasia.

Authors:  Nicole Barnes; Wassim Chemaitilly
Journal:  Front Pediatr       Date:  2014-09-23       Impact factor: 3.418

5.  Predictive Value of Dental Maturity for a Positive Gonadotropin-Releasing Hormone Stimulation Test Result in Girls with Precocious Puberty.

Authors:  Jee Seon Baik; Jin Woo Choi; Su Jin Kim; Ji Hyun Kim; Sollip Kim; Jae Hyun Kim
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

6.  Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty.

Authors:  Hye Ryun Kim; Hyo-Kyoung Nam; Young-Jun Rhie; Kee-Hyoung Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-12-31

7.  The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty.

Authors:  Sung Woo Kim; Young Bae Kim; Jeong Eun Lee; Na Ri Kim; Weon Kyung Lee; Jae Kyun Ku; Eun Jeong Kim; Sun Hee Jung; Woo Yeong Chung
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-06-28

8.  Usefulness of pelvic ultrasonography for the diagnosis of central precocious puberty in girls.

Authors:  Jung Yu; Ha Young Shin; Sun Hee Lee; You Sung Kim; Jae Hyun Kim
Journal:  Korean J Pediatr       Date:  2015-08-21

9.  Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue.

Authors:  Romina P Grinspon; Luz Andreone; Patricia Bedecarrás; María Gabriela Ropelato; Rodolfo A Rey; Stella M Campo; Ignacio Bergadá
Journal:  Int J Endocrinol       Date:  2013-11-12       Impact factor: 3.257

10.  Diurnal variation of gonadotropin levels in girls with early stages of puberty.

Authors:  Yu Sun Kang; Dong-Yoon Yoo; In Hyuk Chung; Eun-Gyong Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.